These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35117418)

  • 1. Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients.
    Wan X; Hong Z; Mao Y; Di W
    Transl Cancer Res; 2020 Feb; 9(2):726-734. PubMed ID: 35117418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
    Wang D; Luo Y; Guo Y; Li G; Li F
    Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
    Hao X; Gu M; Sun J; Cong L
    J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
    Gu L; Yao Y; Chen Z
    Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
    Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
    Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients.
    Lin R; Zhao S; Su L; Chen X; Xu C; He Q; Zhuo C; Ye Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23350. PubMed ID: 32672362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer.
    Luo X; Tai J; Zhao Y; Zhao P; Sun D; Wang L
    Oncol Lett; 2022 Oct; 24(4):348. PubMed ID: 36072008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
    Liu Y; Tian J; Qin D; Liu J; Xie Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
    Zhang L; Tao H; Ke K; Ma C
    J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
    Fang T; Lu Q
    J Clin Lab Anal; 2020 Jun; 34(6):e23213. PubMed ID: 32133702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of a kinase interacting protein 1 in tongue squamous cell carcinoma correlates with lymph node metastasis and poor overall survival.
    Sun Y; Shi G; Ma C; Jiao J; Liu Y; Gao Q; Zhang X; Feng Q
    Medicine (Baltimore); 2021 Apr; 100(14):e25278. PubMed ID: 33832094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.
    Zhang W; Wu Q; Wang C; Yang L; Liu P; Ma C
    Mol Cell Biochem; 2018 Nov; 448(1-2):311-320. PubMed ID: 29520695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated AKIP1 expression is associated with tumor invasion, shorter survival time and decreased chemosensitivity in endometrial carcinoma.
    Li A; Li A; Gao X; Zhang T; Ma Z; Xiao Y; Zhao F
    Oncol Lett; 2022 Aug; 24(2):268. PubMed ID: 35782897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
    Shen S; Yao Y
    Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of A-kinase interacting protein 1 expression in various cancers: A meta-analysis based on the Chinese population.
    Xue S; Zhang C; Xu J; Zhou C
    Medicine (Baltimore); 2022 Jun; 101(25):e29203. PubMed ID: 35758348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
    Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
    Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
    Yan Y; Li X; Gao J
    J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-α7 expression positively correlates with CD44 and CD133 expressions, and its high expression associates with advanced tumor features as well as poor survivals in non-small cell lung cancer patients.
    Shi X; Wen F; Xu G; Hu Y
    Transl Cancer Res; 2019 Sep; 8(5):1806-1816. PubMed ID: 35116931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer.
    Jiang W; Yang W; Yuan L; Liu F
    Onco Targets Ther; 2018; 11():6795-6801. PubMed ID: 30349312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.